Kid Psoriasis Drug Approved

Kid Psoriasis Drug Approved

Young people living with plaque psoriasis have been challenged in treatment options due to their age and duration restrictions for super potent steroids. The U.S. Food and Drug Administration (FDA) has approved LEXETTE® (halobetasol propionate) a super potent topical corticosteroid in patients with psoriasis plaques age 12 years and older. LEXETTE is a 0.05% foam application approved for adolescents because of its tolerability and its ability to treat more affected surface areas.

According to the National Psoriasis Foundation, psoriasis is a chronic inflammatory disease affecting approximately 8 million Americans each year and 1% of children and adolescents in the United States. Plaque psoriasis is the most common form affecting about 80 percent of the people living with the condition.

Symptoms of plaque psoriasis appear itchy, painful, raised and inflamed scaly patches of skin. Plaques usually appear symmetrically on the body, affecting both sides of the body in the same area, most often on the scalp, knees, elbows and torso.

According to Mayne Pharma, the FDA approved LEXETTE in 2018 based on evidence from two multicentre, randomized, double-blind, vehicle-controlled studies (n=560) in patients with plaque psoriasis involving between 2% to 12% body surface area. Additional data were obtained in a follow-on open label study in patients aged 12 to 17 years of age with plaque psoriasis. The adolescent trial showed favorable results similar to the foam’s previously demonstrated safety and tolerability profile in adults.

About The Author

Kendra Evans

Kendra Evans founded Inflammation Guide in April 2020. Our goal is keeping our readers informed to help them live an empowered and full life while they manage inflammation. Inflammation Guide provides a central location for breaking news and updates on prescriptions, treatments, supplements and alternative wellness solutions to give options to people living with at least one inflammatory condition.

inflammation guide logo

You have Successfully Subscribed!